Optimization and robustness of blood tests for liver fibrosis and cirrhosis

Clinical Biochemistry

Volumn 43, Issue 16-17, 2010, Pages 1315-1322

  Cales P ^a,b   Boursier, Jérôme ^a,b   Bertrais, S ^b   Oberti, Frédéric ^a,b   Gallois, Yves ^a   Fouchard Hubert, Isabelle ^a,b   Dib, Nina ^a,b   Zarski, Jean Pierre ^c,d   Rousselet, Marie Christine ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

Blood test; Bootstrap.; Diagnosis; Diagnostic accuracy; Fibroscan; Hepatitis C; Liver biopsy; Liver fibrosis

Indexed keywords

HYALURONIC ACID;

ARTICLE; BLOOD ANALYSIS; BOOTSTRAPPING; COST; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE COURSE; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TASK PERFORMANCE; VALIDATION STUDY; VIRUS HEPATITIS;

AREA UNDER CURVE; BIOLOGICAL MARKERS; HEMATOLOGIC TESTS; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 77957327974     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.08.010     Document Type: Article

References (34)

1. Oberti F., Valsesia E., Pilette C., Rousselet M.C., Bedossa P., Aube C., et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997, 113:1609-1616.
2. Cales P., Oberti F., Michalak S., Hubert-Fouchard I., Rousselet M.C., Konate A., et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005, 42:1373-1381.
3. Cales P., de Ledinghen V., Halfon P., Bacq Y., Leroy V., Boursier J., et al. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int 2008, 28:1352-1362.
4. Zarski J.P., Sturm N., Guechot J., Paris A. Independent and prospective comparison of 9 surrogate markers for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009, 50:1061A.
5. Degos F., Perez P., Roche B., Mahmoudi A., Asselineau J., Voitot H., et al. Performances of Fibroscan® for diagnosis of significant fibrosis and cirrhosis. A prospective study of 1993 patients with chronic viral hepatitis. J Hepatol 2009, 50:S40.
6. Steyerberg E.W., Harrell F.E., Borsboom G.J., Eijkemans M.J., Vergouwe Y., Habbema J.D. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001, 54:774-781.
7. Leroy V., Halfon P., Bacq Y., Boursier J., Rousselet M.C., Bourliere M., et al. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data. Clin Biochem 2008, 41:1368-1376.
8. Cales P., Veillon P., Konate A., Mathieu E., Ternisien C., Chevailler A., et al. Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem 2008, 41:10-18.
9. Khoo E., Stephenson M., Leverton E., Cross R., Morris P., Macdonald I., et al. Effect of mixed meal challenge on Liver fat content and serum markers of liver fibrosis - does food deliver an invisible second hit?. Hepatology 2009, 50:792A.
10. Poynard T., Imbert-Bismut F., Munteanu M., Messous D., Myers R.P., Thabut D., et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004, 3:8.
11. Calès P., Halfon P., Batisse D., Carrat F., Perré P., Penaranda G., et al. Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. J Hepatol 2010, 52:238-244.
12. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-350.
13. Adams L.A., Bulsara M., Rossi E., DeBoer B., Speers D., George J., et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005, 51:1867-1873.
14. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994, 20:15-20. The French METAVIR Cooperative Study Group.
15. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 2003, 49:7-18.
16. Armitage P., Berry G. Intraclass correlation: statistical methods in medical research 1994, 273-276. Blackwell Science, Oxford.
17. Austin P.C. Using the bootstrap to improve estimation and confidence intervals for regression coefficients selected using backwards variable elimination. Stat Med 2008, 27:3286-3300.
18. Parkes J., Guha I.N., Roderick P., Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006, 44:462-474.
19. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
20. Halfon P., Bacq Y., De Muret A., Penaranda G., Bourliere M., Ouzan D., et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 2007, 46:395-402.
21. Cacoub P., Carrat F., Bedossa P., Lambert J., Penaranda G., Perronne C., et al. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study - ANRS HC02. J Hepatol 2008, 48:765-773.
22. Bottero J., Lacombe K., Guechot J., Serfaty L., Miailhes P., Bonnard P., et al. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. J Hepatol 2009, 50:1074-1083.
23. Thein H.H., Yi Q., Dore G.J., Krahn M.D. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 2008, 48:418-431.
24. Thein H.H., Yi Q., Dore G.J., Krahn M.D. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 2008, 22:1979-1991.
25. Rosenberg W.M., Voelker M., Thiel R., Becka M., Burt A., Schuppan D., et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004, 127:1704-1713.
26. Patel K., Gordon S.C., Jacobson I., Hezode C., Oh E., Smith K.M., et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004, 41:935-942.
27. Zarski J.P., Mc Hutchison J., Bronowicki J.P., Sturm N., Garcia-Kennedy R., Hodaj E., et al. Rate of natural disease progression in patients with chronic hepatitis C. J Hepatol 2003, 38:307-314.
28. Boursier J., Konate A., Gorea G., Reaud S., Quemener E., Oberti F., et al. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol 2008, 6:1263-1269.
29. Gader A., Bahakim H., Awadalla S., Malaika S. Ethnic variations in the haemostatic system: comparison between Arabs, Westerners (Europeans and Americans), Asians and Africans. Blood Coagul Fibrinolysis 1995, 6:537-542.
30. Mayr F.B., Spiel A.O., Leitner J.M., Firbas C., Jilma-Stohlawetz P., Chang J.Y., et al. Racial differences in endotoxin-induced tissue factor-triggered coagulation. J Thromb Haemost 2009, 7:634-640.
31. Bonnard P., Sombie R., Lescure F.X., Bougouma A., Guiard-Schmid J.B., Poynard T., et al. Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso. Am J Trop Med Hyg 2010, 82:454-458.
32. Wu S.D., Wang J.Y., Li L. Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: a comparative study. World J Gastroenterol 2010, 16:501-507.
33. Gressner O.A., Beer N., Jodlowski A., Gressner A.M. Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis. Clin Chim Acta 2009, 409:90-95.
34. Boursier J., Bacq Y., Halfon P., Leroy V., de Ledinghen V., de Muret A., et al. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol 2009, 21:28-38.